Covered recipient · General Payments record
LAURA C WESTON
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$1,584.17
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $326.76 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $75.07 | 4 |
| Biogen, Inc. | $56.16 | 2 |
| Biosense Webster, Inc. | $35.36 | 1 |
| MILLICENT US INC | $34.33 | 2 |
| Exact Sciences Corporation | $34.11 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $27.17 | 3 |
| Astellas Pharma US Inc | $24.62 | 1 |
| Sumitomo Pharma America, Inc. | $22.42 | 1 |
| CooperSurgical, Inc. | $17.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.33 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106328829 | CMS |
| ABBVIE INC. | $19.02 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106328831 | CMS |
| ABBVIE INC. | $17.99 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106328833 | CMS |
| ABBVIE INC. | $17.73 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106328835 | CMS |
| Astellas Pharma US Inc | $24.62 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139297212 | CMS |
| Biogen, Inc. | $28.79 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104875410 | CMS |
| Biogen, Inc. | $27.37 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104853724 | CMS |
| Biosense Webster, Inc. | $35.36 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077670944 | CMS |
| CooperSurgical, Inc. | $17.52 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150799223 | CMS |
| Exact Sciences Corporation | $34.11 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114948057 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $8.76 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154703371 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $7.64 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154703375 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $10.77 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154703369 | CMS |
| MILLICENT US INC | $18.45 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150913289 | CMS |
| MILLICENT US INC | $15.88 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150913293 | CMS |
| Sumitomo Pharma America, Inc. | $22.42 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148934720 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.